Preface |
|
vii | |
Introduction The Lay of the Land |
|
ix | |
|
Contributors |
|
xv | |
|
SECTION I THE SCIENTIFIC RATIONALE FOR GLOBAL ISSUES AFFECTING DIABETES IN PREGNANCY |
|
|
|
Chapter 1 The Professional Responsibility Model of Obstetric Ethics: Clinical Application to the Management of Diabetes in Pregnancy |
|
|
3 | (6) |
|
|
|
Chapter 2 Evidence-Based Medical Practice: Its Use and Misuse |
|
|
9 | (8) |
|
|
|
Chapter 3 Pharmacologic Considerations Affecting Hypoglycemic Therapy During Pregnancy |
|
|
17 | (12) |
|
|
|
|
Chapter 4 Pharmacotherapy for Diabetes in Pregnancy: Critical Review of Fetal Safety |
|
|
29 | (12) |
|
|
|
Chapter 5 Diabetes and Related Metabolic States and the Placenta |
|
|
41 | (12) |
|
|
|
|
Chapter 6 Metabolic and Hormonal Changes in Normal and Diabetic Pregnancy |
|
|
53 | (10) |
|
|
|
Chapter 7 Fetal Macrosomia: Etiological Factors |
|
|
63 | (12) |
|
|
Chapter 8 Fetal Growth Restriction |
|
|
75 | (24) |
|
|
|
SECTION II THE SCIENTIFIC RATIONALE FOR THE MANAGEMENT OF DIABETES IN PREGNANCY |
|
|
|
PART I Outcome Measurements of Diabetes in Pregnancy |
|
|
|
Chapter 9 The Infant of the Diabetic Mother: Short-Term Implications and Management |
|
|
99 | (10) |
|
|
|
|
Chapter 10 Life Span Outcomes for the Child of the Diabetic Mother |
|
|
109 | (12) |
|
|
|
PART II General Clinical Management of the Pregnant Diabetic |
|
|
|
Chapter 11 Glucose Monitoring in Pregnancy Compromised by Diabetes |
|
|
121 | (10) |
|
|
|
Chapter 12 Innovations in the Application of Advanced Glucose Sensing Technologies to Clinical Decision Making: CGM in Practice |
|
|
131 | (10) |
|
|
|
|
Chapter 13 Patient Compliance: The Elusive Variable in Diabetes Management |
|
|
141 | (8) |
|
|
Chapter 14 The Association Between Glucose Thresholds and Perinatal Complications |
|
|
149 | (14) |
|
|
Chapter 15 Medical Nutrition Therapy |
|
|
163 | (12) |
|
|
|
|
Chapter 16 The Use of Insulin in Diabetes in Pregnancy: From the Old to the New |
|
|
175 | (14) |
|
|
Chapter 17 Exercise: The Logical Intervention for Diabetes in Pregnancy |
|
|
189 | (8) |
|
|
|
Chapter 18 The Genetic Architecture of Diabetes in Pregnancy |
|
|
197 | (8) |
|
|
|
|
|
Chapter 19 Fetal Testing in Pregnancies Complicated by Diabetes Mellitus: Why, How, and for Whom? |
|
|
205 | (14) |
|
|
Chapter 20 Hypertensive Disorders in Pregnancy Complicated by Diabetes |
|
|
219 | (14) |
|
|
|
PART III Pregnancy Complicated by Gestational Diabetes Mellitus |
|
|
|
Chapter 21 Pathogenesis of Gestational Diabetes Mellitus |
|
|
233 | (10) |
|
|
|
Chapter 22 Gestational Diabetes: The Consequences of Not Treating |
|
|
243 | (14) |
|
|
Chapter 23 Obesity in Pregnancy: A Sign of the Times? |
|
|
257 | (22) |
|
|
Chapter 24 The Metabolic Syndrome and Long-Term Implications for the Mother |
|
|
279 | (12) |
|
|
|
Chapter 25 Screening for Gestational Diabetes |
|
|
291 | (8) |
|
|
Chapter 26 Gestational Diabetes: A Diagnostic Dilemma? A Difference, to be a Difference, Must Make a Difference |
|
|
299 | (12) |
|
|
Chapter 27 Oral Antidiabetic Agents in Pregnancy: Their Time Has Come |
|
|
311 | (24) |
|
|
Chapter 28 The Role of Polycystic Ovary Syndrome: Management of Type 2 and Gestational Diabetes Mellitus |
|
|
335 | (8) |
|
|
PART IV Pregnancy Complicated by Pre-existing Diabetes |
|
|
|
Chapter 29 Preconception Care in Diabetes: Shortcomings and Challenges |
|
|
343 | (6) |
|
|
Chapter 30 Epidemiology and Prenatal Diagnosis of Congenital Malformations in Diabetic Embryopathy |
|
|
349 | (14) |
|
|
|
Chapter 31 Type 2 Diabetes in Pregnancy: A Growing Concern |
|
|
363 | (16) |
|
|
Chapter 32 Diabetic Ketoacidosis in Pregnancy |
|
|
379 | (8) |
|
|
|
Chapter 33 Confronting Hypoglycemia in the Pregnant Diabetic |
|
|
387 | (14) |
|
|
Chapter 34 Diabetic Retinopathy |
|
|
401 | (8) |
|
|
|
|
Chapter 35 Diabetic Nephropathy in Pregnancy |
|
|
409 | (12) |
|
|
|
|
Chapter 36 Fetal Lung Maturation in Pregnancies Complicated by Maternal Diabetes |
|
|
421 | (4) |
|
|
|
Chapter 37 Timing and Mode of Delivery |
|
|
425 | (14) |
|
|
Chapter 38 Management of Labor: Augmentation, Induction, and Glucose Control |
|
|
439 | (6) |
|
|
Index |
|
445 | |